Hormone therapy and erectile dysfunction: what to know

Hormone therapy can cause erectile dysfunction (ED) as a side effect, depending on which hormones are used and why they are prescribed. ^[1] Low levels of testosterone are a well‑known physical cause of ED, and some therapies intentionally lower testosterone (for example, androgen deprivation therapy for prostate cancer), which can reduce sex drive and make getting or keeping an erection harder. ^{[2] [1]}

On the other hand, when ED is linked to genuinely low testosterone, properly monitored testosterone replacement therapy can improve erections and sexual desire for some men. ^[3] This benefit is most likely when blood testosterone is low or low‑normal and ED symptoms are present, though individual response varies and safety must be assessed. [PM16]

---

Why ED happens with hormone therapy

• Reduced testosterone signaling: Testosterone supports the erection pathway (including nitric oxide activity); lowering it can reduce libido and penile rigidity. ^[2]
• Cancer treatments: Hormone therapy used for prostate cancer frequently lists loss of sex drive and ED among expected side effects. ^[1]
• Emotional and stress factors: The brain and emotions play a key role in arousal; stress, depression, and anxiety can worsen ED alongside hormonal changes. ^[4]

---

Who is most affected

• People receiving androgen deprivation therapy (ADT) or maximal androgen blockade for prostate cancer often experience decreased libido and erectile difficulties as part of the treatment profile. ^[1]
• People with naturally low testosterone (hypogonadism) can have ED; in these cases, supervised testosterone therapy may help when appropriate. ^{[2] [3]}

---

Symptoms to watch

• Lower sexual desire, fewer spontaneous erections, difficulty maintaining erections to orgasm, or shorter duration of rigidity. ^[5]
• Mood changes or breast swelling can also be signs of low testosterone when ED and low libido coexist. ^[6]

---

Evidence-based ways to cope

Optimize overall health

• Manage blood pressure, cholesterol, diabetes, weight, sleep apnea, smoking, and alcohol, as these factors commonly worsen ED and can be modified. ^[7]
• Address relationship or psychosocial issues; counseling or sex therapy can improve outcomes when anxiety or communication barriers play a role. ^[7]

First-line ED medications

• Phosphodiesterase‑5 inhibitors (PDE5i) such as sildenafil, tadalafil, or vardenafil are considered first‑line and can be safe and effective across a wide age range, with about a 60% response rate overall. ^[8]

Non‑oral and device options

• Vacuum erection devices, intraurethral alprostadil (MUSE), or penile injections are standard second‑line therapies if pills are not sufficient. ^[8]
• Structured penile rehabilitation programs after cancer therapy may use early, regular erections (via medications, devices, or injections) to support recovery. ^[9]

Testosterone therapy in selected cases

• When blood tests confirm low testosterone in someone with ED and low libido, testosterone replacement (gel, patch, injection, or other forms) can be considered, often alongside PDE5i, after weighing benefits and risks. ^[3]
• Research suggests testosterone can improve sexual symptoms in hypogonadal men, though results vary and careful monitoring is essential. [PM13] [PM14] [PM16]

---

Practical tips users can try

• Keep a regular schedule for ED medicines and plan sexual activity to match onset and duration (for example, daily low‑dose tadalafil vs on‑demand sildenafil). ^[8]
• Use a vacuum device with a tension ring to maintain erections if medications are not enough. ^[8]
• Involve partners in discussions to reduce anxiety and improve intimacy; consider counseling when stress or mood symptoms are present. ^{[4] [7]}
• Ask about referral to a urologist specialized in sexual medicine to tailor therapy and monitor side effects. ^[10]

---

Safety reminders

• If you are on prostate cancer hormone therapy, ED and reduced libido can be expected; talk with your oncology and urology teams early about sexual side effects and rehabilitation options. ^{[1] [9]}
• Testosterone therapy should not be used to counteract cancer‑directed androgen deprivation unless your specialist explicitly recommends it; safety and cancer control come first. ^[1]
• Any ED treatment plan should include evaluation of cardiovascular risks and medication interactions, especially if nitrates or certain heart drugs are used. ^{[7] [8]}

---

When to seek help

• New or worsening ED that affects quality of life, particularly with low energy, mood changes, or breast swelling, warrants evaluation for possible low testosterone and other causes. ^{[6] [5]}
• Persistent ED despite lifestyle changes and first‑line medications should prompt discussion of second‑line options or penile rehabilitation strategies. ^{[8] [9]}

---

Bottom line

• Hormone therapy that lowers testosterone, such as treatment for prostate cancer, can cause ED and reduced sex drive. This is a recognized and common side effect, and support is available. ^[1]
• A stepwise approach risk factor optimization, first‑line PDE5 inhibitors, second‑line devices or injections, and selective testosterone therapy for true deficiency helps many people regain sexual function. ^{[7] [8] [3]} [PM16]
• Discuss your specific treatment plan and goals with your clinicians, as responses vary and safety considerations differ by condition and medication. ^{[7] [8]}